Follow

Submissions from 2024

 

In Reply to Cellini and Fiore, Michael Chuong

 

Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease, Venkataraghavan Ramamoorthy and Muni Rubens

 

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, Noah Kalman, and Adeel Kaiser

PDF

International survey on opinions and use of robot-assisted and laparoscopic minimally invasive pancreatic surgery: 5-year follow up, Horacio Asbun

 

Irreversible Electroporation in Treating Colorectal Liver Metastases in Proximity to Critical Structures, Govindarajan Narayanan, Nicole Gentile, Jonathan Eyshi, Brian Schiro, Ripal Gandhi, Constantino Pena, Antonio Ucar, Santiago Aparo, Fernando de Zarraga, Sarah Joseph, Horacio Asbun, and Madelon Dijkstra

 

Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study, Guenther Koehne

 

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval-Leon

 

Management of Postoperative Discitis with Debridement and Novel Technique of Local Antibiotic Instillation: Functional Outcomes from a Resource-Limited Setting, Ahmad Ozair

 

MicroRNA Expression in Exosome Extracellular Vesicles as Targets for Personalized Medicine in Diffuse Large B Cell Lymphoma Patients with HIV Infection, Janelle Vicens and Marco RuizAndia

 

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial, Antonio Ucar

 

Molecular remodeling in comorbidities associated with heart failure: a current update, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Sandra Chaparro, and Javier Jimenez

 

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

 

Online videos of robotic-assisted cholecystectomies: more harm than good?, Domenech Asbun

 

Osseous Maxillary Reconstruction with Immediate Dental Implant Placement: An Optimized Workflow for the Oncologic Patient, Evan Rosen

 

OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL, Yuliya Linhares

 

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

 

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

 

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Rohan Garje and Bruno Bastos

 

Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study, Arjun Pon Avudaiappan, Pushan Prabhakar, Muni Rubens, Rohan Garje, Ahmed Eldefrawy, and Murugesan Manoharan

 

Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez and Eduardo Pons

 

Pediatric Cranial Stereotactic Radiosurgery: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Anshul Saxena, Md Ashfaq Ahmed, and Rupesh Kotecha

 

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

 

Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis, Mainak Bardhan

 

Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma, Guilherme Rabinowits

 

Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases, Manmeet Ahluwalia